-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Uterine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Uterine Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Uterine Cancer Drug Details: KB-0742 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Myxoid Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Myxoid Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Myxoid Liposarcoma Drug Details: KB-0742 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Ewing Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Ewing Sarcoma Drug Details: KB-0742 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Solid Tumor Drug Details: KB-0742 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Germ Cell Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Germ Cell Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Germ Cell Tumors Drug Details: KB-0742 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPL-84 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPL-84 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SPL-84 in Cystic Fibrosis Drug Details: SPL84-23-1 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ORYN-1001 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ORYN-1001 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ORYN-1001 in Rheumatoid Arthritis Drug Details: ORYN-1001 is under development for the...
-
Product Insights
NewNet Present Value Model: Pharvaris NV’s PHVS-416
Empower your strategies with our Net Present Value Model: Pharvaris NV's PHVS-416 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-001 in Neuroinflammation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KB-001 in Neuroinflammation Drug Details: KB-001 is under development for the treatment of Alzheimer's disease,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-001 in Dementia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KB-001 in Dementia Drug Details: KB-001 is under development for the treatment of Alzheimer's disease,...